Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis

References

• Macaulay WL. Lymphomatoid papulosis:a continuing self-healing eruption, clinically benignehistologically malignant. Arch Dermatol 1968;97:23–30.
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.
   PubMed Web of Science ®Google Scholar
• Rafkiaer W, Willemze R, Paulli M, et al. Primary cutaneous CD30-postitive T-cell lymphoproliferative disorders. In Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 300–301.
   Google Scholar
• Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30 + lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000;95:3653–3661.
   PubMed Web of Science ®Google Scholar
• Wang HH, Myers T, Lach LJ, et al. Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 1999;86:1240–1245.
   PubMed Web of Science ®Google Scholar
• Beljaards RC, Willemze R. The prognosis of patients with LyP associated with malignant lymphomas. Br J Dermatol 1992;126: 596–602.
   PubMed Web of Science ®Google Scholar
• el-Azhary RA, Gibson LE, Kurtin PJ, et al. Lymphomatoid papulosis:a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies. J Am Acad Dermatol 1994;30:210–218.
   PubMed Web of Science ®Google Scholar
• Shabrawi-Caelen LE, Kerl H, Cerroni L. Lymphomatoid papulosis. Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004;140:441–447.
   PubMed Web of Science ®Google Scholar
• Saggini A, Gulia A, Argenyi Z, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8 + cytotoxic T-cell lymphoma. Description of 9 cases. Am J Surg Pathol 2010;34:1168–1175.
   PubMed Web of Science ®Google Scholar
• Kempf W, Kazakov DV, Schärer L, et al. Angioinvasive lymphomatoid papulosis:a new variant simulating aggressive lymphomas. Am J Surg Pathol 2013;37:1–13.
   PubMed Web of Science ®Google Scholar
• De Souza A, el-Azhary RA, Camilleri MJ, et al. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol 2012;66:928–937.
   PubMed Web of Science ®Google Scholar
• Liu HL, Hoppe RT, Kohler S, et al. CD30 + cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol 2003;49:1049–1058.
   PubMed Web of Science ®Google Scholar
• Gan EY, Tang MB, Tan SH. Lymphomatoid papulosis: is a second lymphoma commoner among East Asians? Clin Exp Dermatol 2012;37:118–121.
   PubMed Web of Science ®Google Scholar
• Kunishige JH, McDonald H, Alvarez G, et al. Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exp Dermatol 2009;34:576–581.
   PubMed Web of Science ®Google Scholar
• Cabanillas F, Armitage J, Pugh WC, et al. Lymphomatoid papulosis: a T-cell dyscrasia with a propensitiy to transform into maligmant lymphoma. Ann Intern Med 1995;122:210–217.
   PubMed Web of Science ®Google Scholar
• Min JA, Oh ST, Kim JE, et al. Lymphomatoid papulosis followed by anaplastic large cell lymphoma in a pediatric patient. Ann Dermatol 2010;22:447–451.
   PubMed Web of Science ®Google Scholar
• Dalle S, Balme B, Thomas L. Lymphomatoid papulosis localized to the face. Dermatol Online J 2006;12:9.
   PubMedGoogle Scholar
• Kempf W, Kazakov DV, Baumgartner HP, et al. Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings. J Am Acad Dermatol 2013;68:809–816.
   PubMed Web of Science ®Google Scholar
• Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol 2013;37:1173–1181.
   PubMed Web of Science ®Google Scholar
• Kempf W, Levi E, Kamarashev J, et al. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol 2002;29:295–300.
   PubMed Web of Science ®Google Scholar
• Basarab T, Fraser-Andrews EA, Orchard G, et al. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol 1998;139:630–638.
   PubMed Web of Science ®Google Scholar
• Christensen H, Thomsen K, Vejlsgaard G. Lymphomatoid papulosis: a follow-up study of 41 patients. Semin Dermatol 1994;13:197–201.
   PubMedGoogle Scholar
• Kempf W, Pfaltz K, Vermeer MH et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders:lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011;118:4024–4035.
   PubMed Web of Science ®Google Scholar
• Hughes PS. Treatment of lymphomatoid papulosis with imiquimod 5% cream. J Am Acad Dermatol 2006;54:546–547.
   PubMed Web of Science ®Google Scholar
• Wyss M, Dummer R, Dommann SN, et al. Lymphomatoid papulosis—treatment with recombinant interferon alfa-2a and etretinate. Dermatology 1995;190:288–291.
   PubMed Web of Science ®Google Scholar
• Schmuth M, Topar G, Illersperger B, et al. Therapeutic use of interferon-alpha for lymphomatoid papulosis. Cancer 2000;89: 1603–1610.
   PubMed Web of Science ®Google Scholar
• van Leeuwen MT, Turner JJ, Falster MO, et al. Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure. Int J Cancer 2013;133:944–951.
   PubMed Web of Science ®Google Scholar
• Fernández-Guarino M, Carrillo-Gijón R, Jaén-Olasolo P. Lymphomatoid papulosis: clinical and pathological findings in 18 patients. Actas Dermosifiliogr 2012;103:388–393.
   PubMedGoogle Scholar
• Gruber R, Sepp NT, Fritsch PO, et al. Prognosis of lymphomatoid papulosis. Oncologist 2006;11:955–957.
   PubMed Web of Science ®Google Scholar
• El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis:reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004;140: 441–447.
   PubMed Web of Science ®Google Scholar
• Thomsen K, Wantzin GL. Lymphomatoid papulosis. A follow-up study of 30 patients. J Am Acad Dermatol 1987;17:632–636.
   PubMed Web of Science ®Google Scholar
• Sina B, Burnett JW. Lymphomatoid papulosis. Case reports and literature review. Arch Dermatol 1983;119:189–197.
   PubMed Web of Science ®Google Scholar
• Sanchez NP, Pittelkow MR, Muller SA, et al. The clinicopathologic spectrum of lymphomatoid papulosis: study of 31 cases. J Am Acad Dermatol 1983;8:81–94.
   PubMed Web of Science ®Google Scholar